Buzz IDEAS

Vedolizumab Effective for Treatment of Ulcerative Colitis Crohns Disease

Vedolizumab Effective for Treatment of Ulcerative Colitis Crohns Disease

Sunanda Kane, M.D., a gastroenterologist at Mayo Clinic specializing in the care and evaluation of patients with IBD, discusses two articles recently published in “The New England Journal of Medicine” that found patients with ulcerative colitis or Crohn’s disease benefited from treatment with vedolizumab compared with placebo. Dr. Kane also discusses how vedolizumab is different than other drugs currently used to treat IBD.

 

Vedolizumab Shown To Be Effective For Treating Inflammatory Bowel Diseases

27, 2013) – The results from two Phase III clinical studies (GEMINI I and II) evaluating Takeda Pharmaceutical Company's vedolizumab, an investigational monoclonal antibody drug for the treatment of ulcerative colitis and Crohn's disease, have been